CARsgen Therapeutics Holdings (HKSE:02171) Long-Term Capital Lease Obligation : HK$68.16 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CARsgen Therapeutics Holdings Long-Term Capital Lease Obligation?

CARsgen Therapeutics Holdings's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$68.16 Mil.

CARsgen Therapeutics Holdings's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 (HK$77.08 Mil) to Jun. 2024 (HK$76.21 Mil) and declined from Jun. 2024 (HK$76.21 Mil) to Dec. 2024 (HK$68.16 Mil).

CARsgen Therapeutics Holdings's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$106.02 Mil) to Dec. 2023 (HK$77.08 Mil) and declined from Dec. 2023 (HK$77.08 Mil) to Dec. 2024 (HK$68.16 Mil).

CARsgen Therapeutics Holdings Long-Term Capital Lease Obligation Historical Data

The historical data trend for CARsgen Therapeutics Holdings's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARsgen Therapeutics Holdings Long-Term Capital Lease Obligation Chart

CARsgen Therapeutics Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

16.62

119.16

106.02

77.08

68.16

CARsgen Therapeutics Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial						106.02	98.31	77.08	76.21	68.16

CARsgen Therapeutics Holdings (HKSE:02171) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

CARsgen Therapeutics Holdings Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of CARsgen Therapeutics Holdings's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

CARsgen Therapeutics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (HKSE:02171) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN

Website

https://www.carsgen.com

CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.

Executives

Bei Jing Shen Nong Tou Zi Guan Li Gu Fen You Xian Gong Si	2102 Investment manager
Candock Holdings Limited	2501 Other
Yi Jie Sheng Wu Ji Shu Kong Gu You Xian Gong Si	2501 Other
Yi De Kong Gu You Xian Gong Si	2501 Other
Quan Zhou Shi Ding Wo Chuang Feng Tou Zi Zhong Xin You Xian He Huo	2501 Other
Yang Xuehong	2501 Other
Wang Huamao	2401 A concert party to an agreement to buy shares
Li Zonghai	2401 A concert party to an agreement to buy shares
Guo Bingsen	2401 A concert party to an agreement to buy shares
Accure Biotech Limited	2501 Other
Cart Biotech Limited	2501 Other
Chen Haiou	2501 Other
Guo Xiaojing	2501 Other
He Xi Holdings Limited	2501 Other
Redelle Holding Limited	2501 Other

CARsgen Therapeutics Holdings Headlines

No Headlines